Policy
Changes
Dashboard
Pricing
Sign in
Sign up free
Home
/
Changes
/
Aetna
/
Inflammatory Disease: Biomarker and Thiopurine Pharmacogenomic Testing (CPB 0249, reviewed 2026-04-27)
Back to dashboard
Low impact
Inflammatory Disease: Biomarker and Thiopurine Pharmacogenomic Testing (CPB 0249, reviewed 2026-04-27)
Aetna
·
Medical Policy
Effective date
Not stated
We identified it
Aug 19, 2026
Days to comply
—
Related policy hubs
Aetna policies
Inflammatory Disease: Biomarker and Thiopurine Pharmacogenomic Testing (CPB 0249, reviewed 2026-04-27) | Aetna | PolicyChanges.app